Speiser, Daniel E.
HilleVax GmbH,
Switzerland
2025 Rank: 42856
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 817 out of 166615 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 42856 | 46976 |
| Total Cites | 2479 | 2622 |
| H-index | 23 | 24 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 59 | 59 |
| Total Cites to Single+First Authored Papers | 232 | 234 |
| Number of Single+First+Last Authored Papers | 129 | 129 |
| Total Cites to Single+First+Last Authored Papers | 554 | 561 |
| Composite Score | 2 | 3 |
| Number of Distinct Citing Papers | 2182 | 2263 |
| Ratio of Total Citations to Distinct Citing Papers | 1.14 | 1.16 |
| Self-Citation Percentage |
5.45%
|
|
Speiser, Daniel E.
Centre Hospitalier Universitaire Vaudois,
Switzerland
2024 Rank: 48567
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 979 out of 157372 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 48567 | 51288 |
| Total Cites | 2307 | 2463 |
| H-index | 22 | 23 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 56 | 56 |
| Total Cites to Single+First Authored Papers | 146 | 152 |
| Number of Single+First+Last Authored Papers | 125 | 125 |
| Total Cites to Single+First+Last Authored Papers | 535 | 554 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1991 | 2088 |
| Ratio of Total Citations to Distinct Citing Papers | 1.16 | 1.18 |
| Self-Citation Percentage |
6.33%
|
|
Speiser, Daniel E.
Université de Lausanne (UNIL),
Switzerland
2023 Rank: 44635
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 994 out of 147556 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 44635 | 47266 |
| Total Cites | 2380 | 2571 |
| H-index | 22 | 23 |
| Hm-index | 7 | 7 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 55 | 55 |
| Total Cites to Single+First Authored Papers | 144 | 154 |
| Number of Single+First+Last Authored Papers | 122 | 122 |
| Total Cites to Single+First+Last Authored Papers | 604 | 634 |
| Composite Score | 2 | 3 |
| Number of Distinct Citing Papers | 2073 | 2191 |
| Ratio of Total Citations to Distinct Citing Papers | 1.15 | 1.17 |
| Self-Citation Percentage |
7.43%
|
|
Speiser, Daniel E.
University Hospital Bern,
Switzerland
2022 Rank: 38487
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 991 out of 138599 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 38487 | 40802 |
| Total Cites | 2328 | 2592 |
| H-index | 23 | 24 |
| Hm-index | 6 | 7 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 57 | 57 |
| Total Cites to Single+First Authored Papers | 171 | 183 |
| Number of Single+First+Last Authored Papers | 122 | 122 |
| Total Cites to Single+First+Last Authored Papers | 678 | 715 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1978 | 2151 |
| Ratio of Total Citations to Distinct Citing Papers | 1.18 | 1.21 |
| Self-Citation Percentage |
10.19%
|
|
Speiser, Daniel E.
Université de Lausanne (UNIL),
Switzerland
2021 Rank: 46998
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1095 out of 127911 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 46998 | 45446 |
| Total Cites | 3143 | 3558 |
| H-index | 27 | 30 |
| Hm-index | 7 | 8 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 57 | 57 |
| Total Cites to Single+First Authored Papers | 225 | 248 |
| Number of Single+First+Last Authored Papers | 117 | 117 |
| Total Cites to Single+First+Last Authored Papers | 991 | 1062 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2615 | 2858 |
| Ratio of Total Citations to Distinct Citing Papers | 1.20 | 1.24 |
| Self-Citation Percentage |
11.66%
|
|
Speiser, Daniel E.
Centre Hospitalier Universitaire Vaudois,
Switzerland
2020 Rank: 53662
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1159 out of 108509 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 53662 | 52890 |
| Total Cites | 1747 | 1985 |
| H-index | 23 | 25 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 54 | 54 |
| Total Cites to Single+First Authored Papers | 156 | 177 |
| Number of Single+First+Last Authored Papers | 112 | 112 |
| Total Cites to Single+First+Last Authored Papers | 636 | 696 |
| Composite Score | 2 | 3 |
| Number of Distinct Citing Papers | 1508 | 1638 |
| Ratio of Total Citations to Distinct Citing Papers | 1.16 | 1.21 |
| Self-Citation Percentage |
11.99%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.